Home > Boards > US Listed > Biotechs >

Endra Life Sciences Inc (NDRA)

NDRA RSS Feed
Add NDRA Price Alert      Hide Sticky   Hide Intro
Moderator: dndodd
Search This Board: 
Last Post: 11/29/2021 8:10:57 AM - Followers: 49 - Board type: Free - Posts Today: 0

1/02/2020 *Updated twice a week*
Market Cap $15,800,000 *The Stock Market Watch*

Shares 8,316,875  *The Stock Market Watch* 
  
Shares Held by Institutions 15.24%  *Sounce CNN Business*




NDRA life Sciences Inc. Is engaged in commercialization of enhanced ultrasound 
technology for the pre-clinical research market. The Company's Nexus 128 system 
combines light-based thermoacoustics and unltrasound, to address the imaging needs
of researchers studying disease models in pre-clinical applications. The Company is
involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation
into new Ultrasound system. The (TAEUS) platform has capabilities and potential clinical 
applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional
ultrasound to visualize changes in tissue temperature, in real time; enabling ultasound to view
blood vessels from any angle, uning only a saline solution contrasting agent, unlike Doppler
ultrasound which requires precise viewing angles, and enabling ultrsound to image blood
flow at the capillary level in a region, organ or tissue.


Price Targets 

The 4 analysts offering 12-month price forecasts for NDRA Life Sciences Inc have a median target of $5.00  *CNN Business*



 
NDRA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NDRA News: ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study 11/29/2021 03:00:00 AM
NDRA News: ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents 11/16/2021 04:15:00 AM
NDRA News: ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update 11/15/2021 11:05:00 AM
NDRA News: ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021 11/08/2021 03:00:00 AM
NDRA News: ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent 10/13/2021 04:00:00 AM
PostSubject
#865   $1.02 in the Premarket. LOL dndodd 11/29/21 08:10:57 AM
#864   96 cents biotech_researcher 11/26/21 11:12:24 PM
#863   Yep actually wouldn't be surprised to see it dndodd 11/22/21 04:08:01 PM
#862   .91 Adrock 11/22/21 04:05:50 PM
#859   Over .95 now Karma is a bitch. dndodd 11/22/21 03:17:26 PM
#858   .9025 Adrock 11/22/21 12:37:26 PM
#857   .8902 Adrock 11/22/21 12:33:14 PM
#856   58,000 offer at .93 Adrock 11/22/21 11:06:18 AM
#855   .91 Adrock 11/22/21 10:37:33 AM
#854   .954 Adrock 11/22/21 10:06:01 AM
#853   No at that time I actually had hope dndodd 11/22/21 09:59:11 AM
#852   So you were predicting it would go Adrock 11/22/21 09:54:17 AM
#851   With Tax Loss selling season upon us it's dndodd 11/22/21 09:45:46 AM
#850   WELCOME Adrock 11/22/21 09:40:41 AM
#849   Will this be below a BUCK today? Adrock 11/22/21 09:09:12 AM
#848   The CEO of Endra has all his wealth biotech_researcher 11/20/21 11:27:44 AM
#847   Yes most likely like TItan it will hit dndodd 11/20/21 09:52:59 AM
#846   Under a buck on Monday pop! Adrock 11/20/21 09:23:22 AM
#845   “It’s undervalued at this price. The world of biotech_researcher 11/19/21 07:32:58 PM
#844   Yep about the time your fav scooper gets dndodd 11/18/21 02:58:53 PM
#843   Looks at the bright side soon we’ll both Adrock 11/18/21 02:32:28 PM
#842   NDRA,ENDRA Life Sciences Inc. CM,R,11/16/2021 9:30:00 AM Adrock 11/17/21 07:07:18 AM
#836   It’s undervalued at this price. The world of dndodd 11/16/21 08:45:39 PM
#835   See you under buck here tomorrow you told Adrock 11/16/21 08:42:48 PM
#832   Going to take out those 99 cent stop/loss. willlbone 11/16/21 01:01:17 PM
#831   True but at Endra’s CEO is NOT delaying dndodd 11/16/21 10:13:24 AM
#829   Doesn’t this new patent have any worth? Suppose not Adrock 11/16/21 09:40:03 AM
#827   Yes and he probably can’t commit to the dndodd 11/16/21 09:38:40 AM
#826   Don't you feel like the statement was to Tonyboons33 11/16/21 09:36:41 AM
#825   Insanity is doing the same thing……? biotech_researcher 11/15/21 09:08:44 PM
#824   Ouch No FDA is a s bad as dndodd 11/15/21 04:39:19 PM
#823   Sonny good luck with TMDI keep scooping dndodd 11/11/21 04:22:54 PM
#822   ditto dndodd 11/11/21 04:20:11 PM
#819   With this market it will reach 52 week dndodd 11/10/21 03:17:17 PM
#818   1.325 Adrock 11/10/21 02:51:28 PM
#817   Oooucch!!! Adrock 11/10/21 01:52:31 PM
#816   1.34 Adrock 11/10/21 01:49:21 PM
#815   1.36 Adrock 11/10/21 01:25:04 PM
#814   I feel for you here. It’s painful. Adrock 11/08/21 02:56:55 PM
#813   Well i suggest you go back to observation dndodd 11/08/21 02:56:20 PM
#812   Actually I know exactly what I’m talking about. Your Adrock 11/08/21 02:54:40 PM
#811   You obviously don't have a clue what you dndodd 11/08/21 02:51:55 PM
#810   They haven’t even done trials and your trying Adrock 11/08/21 02:39:08 PM
#809   Exactly why TMDI is way off it's highs!! dndodd 11/08/21 02:37:15 PM
#808   Stock behavior makes one wonder if an approval Adrock 11/08/21 02:36:18 PM
#807   Still waiting for FDA news and sales. dndodd 11/08/21 02:34:17 PM
#806   1.40 now?? What’s happening here I thought only Adrock 11/08/21 02:32:32 PM
#805   1.42? Adrock 11/08/21 01:42:46 PM
#804   I don't expect any revenue in the 3rd dndodd 11/04/21 07:12:18 PM
#803   What news? Cincinnatus 11/04/21 06:42:39 PM
PostSubject
Consent Preferences